Shop / PT-141
For laboratory research use only
Female Libido & Vitality
PT-141
10mg · Lyophilised Powder
$89.00
PT-141 (Bremelanotide) works through the central nervous system — not hormonal pathways — making it uniquely effective for women whose libido decline is neurological rather than purely oestrogen-driven. It activates melanocortin receptors in the brain to restore desire at its source.
Key Highlights
10mg PT-141 per vial — lyophilised for stability
≥99% purity, HPLC-verified
Central melanocortin receptor agonist (MC3R, MC4R)
Studied specifically for female sexual dysfunction (HSDD)
Works via CNS pathways, not hormonal mechanisms
Sterile glass vial, GMP-certified manufacture
Why This Compound Matters for Women
PT-141, or Bremelanotide, is a synthetic analogue of the naturally occurring melanocyte-stimulating hormone α-MSH. Unlike most interventions for female sexual dysfunction — which target oestrogen, testosterone, or vascular mechanisms — PT-141 works centrally, activating melanocortin receptor subtypes (MC3R and MC4R) in the hypothalamus to initiate sexual arousal signals directly within the brain. This is a critical distinction for women. Female libido is profoundly neurological: it is mediated by desire, mood, stress, and central nervous system signalling as much as it is by hormones. Many women experience libido loss even when hormone levels are ostensibly managed — because the central pathways remain dysregulated. PT-141 was investigated in clinical trials specifically for hypoactive sexual desire disorder (HSDD) in women, making it one of the few compounds with female-specific clinical research in this domain. For women whose sense of vitality and intimate connection has been quietly eroded by hormonal transition, PT-141 addresses a dimension of wellbeing that most peptide protocols ignore entirely.
Research Areas
For research context only. All applications are laboratory use.
Central Desire Pathways
PT-141 acts on melanocortin receptors in the hypothalamus — the brain region governing sexual arousal signals. This central mechanism is studied as a direct intervention for women whose libido decline is neurological rather than peripheral.
Hypoactive Sexual Desire Disorder
Clinical research has investigated PT-141 in the context of HSDD — one of the most prevalent and least-treated manifestations of hormonal transition in women. It is among the few peptides with female-specific clinical trial data.
Non-Hormonal Mechanism
Unlike oestrogen or testosterone-based interventions, PT-141 operates independently of the hormonal axis — making it a research option for women who cannot or choose not to use hormone-based approaches.
Mood, Motivation & Vitality
Melanocortin receptor activation has broader neurological effects beyond sexual function — studies explore its role in mood modulation, motivation, and the general sense of vitality and engagement that many women report declining through midlife.
Specifications
Research Use Only. Not intended for human or veterinary use. Handle with sterile technique. Store refrigerated between 2–8°C.